Trends in drug use and prescription patterns for Crohn's disease patients in China, 2018-2022.

However, unlike some other studies [ 1 , 2 , 20 ], we did not find an increasing trend in the percentage of older CD patients.

also in 63,971 other papers

In terms of prescription value, the total cost in the seven regions of China did not show a significant trend from 2018 to 2022, while the prescription expenditure for CD patients increased from 2.83 million Chinese Yuan (CNY) in 2018 to 10.61 million CNY in 2022, and the proportion of expenditure increased from 0.06% in 2018 to 0.19% in 2022 ( p < 0.01), which was shown in Table 1 and Fig. 1 .

also in 9,775 other papers

Table 1 shows that the number of visits did not exhibit a clear trend, decreasing from 155,998,815 in 2018 to 135,692,290 in 2022.

also in 19,460 other papers